Track topics on Twitter Track topics that are important to you
European CAR-T stocks have jumped following Gilead’s announcement that it will acquire Kite Pharma, Novartis’ main competitor to launch the first therapy. Yesterday, Gilead bought a $11.9Bn (€9.9Bn) ticket to enter the final leg of the race to launch the first ...
This awesome article Gilead’s €10Bn Buyout of Kite Pharma Shakes European CAR-T Stocks appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)
Original Article: Gilead’s €10Bn Buyout of Kite Pharma Shakes European CAR-T StocksNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...